GT Biopharma, Inc. (GTBP) › Capital ExpendituresGT Biopharma, Inc. (GTBP) — Capital ExpendituresAnnual figures by period end, from SEC filings.2011-12-31: $02012-12-31: $2.0K2013-12-31: $02014-12-31: $6.0K2015-12-31: $1.0K2016-12-31: $02017-12-31: $4.0K2018-12-31: $36.0K2019-12-31: $0$02011-12-31Capital Expenditures (USD)2019-12-31Period endedCapital ExpendituresChange YoYSource filing2019-12-31$0-100.0%2020-03-27From 2019-01-012018-12-31$36.0K+800.0%2020-03-27From 2018-01-012017-12-31$4.0K—2019-03-29From 2017-01-012016-12-31$0-100.0%2018-03-01From 2016-01-012015-12-31$1.0K-83.3%2018-02-28From 2015-01-012014-12-31$6.0K—2018-02-28From 2014-01-012013-12-31$0-100.0%2015-03-31From 2013-01-012012-12-31$2.0K—2015-01-08From 2012-01-012011-12-31$0—2014-11-18From 2011-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)